Clinical trial
Alefacept for Chronic Graft Versus Host Disease
NCT00397332 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00397332 |
|---|---|
| Title | Alefacept for Chronic Graft Versus Host Disease |
| Official title | An Investigator Initiated Open-label and Explorative Study of Alefacept Treatment for Chronic Extensive Graft Versus Host Disease |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Resistant Chronic GVHD |
| Intervention type | Drug |
| Interventions | Alefacept |
| Enrollment | 20 |
| Start date | Oct 1, 2006 |
| Primary completion | Jan 1, 2013 |
| Completion | Jul 1, 2013 |
| First posted | Nov 9, 2006 |
| Last update posted | Apr 21, 2015 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: